New scan could spot hidden myeloma lesions
NCT ID NCT07319897
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study will test a new type of PET/CT scan that uses a special tracer to find BCMA, a protein on myeloma cells. The goal is to see if this scan can more accurately detect active myeloma throughout the body compared to standard methods. About 300 people with suspected or known multiple myeloma will take part.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for MULTIPLE MYELOMA are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
Beijing An Zhen Hospital of the Capital University of Medical Sciences
RECRUITINGBeijing, Beijing Municipality, China
-
Beijing Tsinghua Changgung Hospital
RECRUITINGBeijing, Beijing Municipality, China
-
First Hospital of Jilin University
RECRUITINGJilin City, Jilin, China
-
Peking University First Hospital
RECRUITINGBeijing, Beijing Municipality, China
-
the Second Hospital of Hebei Medical University
RECRUITINGShijiazhuang, Hebei, China
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Could muscle loss predict blood cancer outcomes?
- Can a Triple-Action antibody deepen remissions in myeloma?
- Can a Low-Dose antifungal shield vulnerable patients from deadly fungal infections?
- Can a gentler chemo prep make stem cell transplants safer for blood cancer patients?
- Talking about the end: could guided conversations reduce futile cancer treatments?
- A guided path back to work after blood cancer: a trial tests the impact